NACDS President Steve Anderson said there remains an urgent need for the current 118th Congress to reform the tactics of market-dominant pharmaceutical middlemen.
Cigna said it “remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive, and have a high probability to close,” per a WSJ report.